Janssen Sciences Ireland Unlimited Company

Janssen Sciences Ireland Uc

Janssen Sciences Ireland Unlimited Company Co Cork, Ie

Antoine Benjamin Michaut

Pierre Jean-Marie Bernard Raboisson

Tim Hugo Maria Jonckers

Patrick René Angibaud

David Francis Alain Lançois

Jérôme Émile Georges Guillemont

Dirk André Emmy Roymans

Anil Koul

Vadim Bichko

Delphine Yvonne Raymonde Lardeau

Boris Rogovoy

Peter Rigaux

David Craig McGowan

Werner Constant Johan Embrechts

Ludwig Paul Cooymans

Guillaume Jean Maurice Mercey

David Craig Mc Gowan

Sabrina Dany France Quatrevaux

Jérome Émile Georges Guillemont

Sovy Chao

David Francis Alain Lancois

David Francis Alain LANÇOIS

Jérôme ÉMile Georges Guillemont

Dirk Andre Emmy Roymans

Jerome Emile Georges Guillemont

Werner Constant Embrechts

Tim Hugo Jonckers

Pierre Jean-Marie Raboisson

Jerome Emile Guillemont

The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection.

Heteroaromatic compounds having activity against RSV

The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection. (Formula I). 

Cycloalkyl substituted pyrazolopyrimidines having activity against RSV

The invention concerns compounds having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection. Formula (Ia). 

Pyrazolopyrimidines having activity against the respiratory syncytial virus (RSV)

The invention concerns novel substituted pyrazolo- and triazolo-pyrimidine compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection. 

RSV antiviral pyrazolo- and triazolo-pyrimidine compounds

The invention relates to compounds having the structure of formula (I) which can be used for the treatment of or against influenza infections.

Indoles for use in influenza virus infection

Growing community of inventors

Illkirch, France

Antoine Benjamin Michaut